Zika and dengue but not chikungunya are associated with Guillain-Barré syndrome in Mexico: A case-control study.
Autorzy:
Grijalva I; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Grajales-Muñiz C; Division of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico. González-Bonilla C; Division of Surveillance Laboratories and Epidemiological Research, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Borja-Aburto VH; Primary Health-Care Unit. Instituto Mexicano del Seguro Social, Mexico City, Mexico. Paredes-Cruz M; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Guerrero-Cantera J; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. González-Ibarra J; Division of Surveillance Laboratories and Epidemiological Research, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Vallejos-Parás A; Division of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Rojas-Mendoza T; Division of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Santacruz-Tinoco CE; Central Laboratory of Epidemiology, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Hernández-Bautista P; Division of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Arriaga-Nieto L; Division of Epidemiological Surveillance of Communicable Diseases, Epidemiologic Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Garza-Sagástegui MG; Medical Provisions for the State Nuevo León, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. Vargas-RamosI; UMAE Hospital de Especialidades No. 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. Sepúlveda-Núñez A; UMAE Hospital de Especialidades No. 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. Campos-Villarreal OI; UMAE Hospital de Especialidades No. 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. Corrales-Pérez R; Medical Epidemiological Assistance Coordination of the State of Nuevo León, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. Azuara-Castillo M; Hospital General de Zona No. 33, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. Sierra-González E; Hospital General de Zona No. 33, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. Meza-Medina JA; Hospital General de Zona No. 33, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. Martínez-Miguel B; Central Laboratory of Epidemiology, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico. López-Becerril G; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Ramos-Orozco J; Hospital General Regional No.1, Instituto Mexicano del Seguro Social, Tijuana, Baja California, Mexico. Muñoz-Guerrero T; Hospital General Regional No.1, Instituto Mexicano del Seguro Social Orizaba, Veracruz, Mexico. Gutiérrez-Lozano MS; Hospital General Regional No.1, Instituto Mexicano del Seguro Social Orizaba, Veracruz, Mexico. Cervantes-Ocampo AA; Hospital General de Zona y Medicina Familiar No. 36, Instituto Mexicano del Seguro Social, Coatzacoalcos, Veracruz, Mexico.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Dec 17; Vol. 14 (12), pp. e0008032. Date of Electronic Publication: 2020 Dec 17 (Print Publication: 2020).
Zika Virus infection and Guillain-Barré syndrome in Northeastern Mexico: A case-control study.
Autorzy:
Gongora-Rivera F; Department of Neurology, University Hospital José Eleuterio González, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León, Mexico. Grijalva I; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Infante-Valenzuela A; Department of Neurology, University Hospital José Eleuterio González, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León, Mexico. Cámara-Lemarroy C; Department of Neurology, University Hospital José Eleuterio González, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León, Mexico. Garza-González E; Department of Gastroenterology, University Hospital José Eleuterio González, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León, Mexico. Paredes-Cruz M; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Grajales-Muñiz C; Epidemiological Surveillance Division for Transmissible Diseases, Epidemiological Surveillance Coordination, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Guerrero-Cantera J; Medical Research Unit for Neurological Diseases, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Vargas-RamosI; Department of Neurology, UMAE Hospital de Especialidades No. 25, Instituto Mexicano del Seguro Social, Monterrey, Nuevo León, Mexico. Soares J; Division of High-Consequence Pathogens and Pathology-Centers for Disease Control and Prevention, Prion and Public Health Office, Atlanta, Georgia, United States of America. Abrams JY; Division of High-Consequence Pathogens and Pathology-Centers for Disease Control and Prevention, Prion and Public Health Office, Atlanta, Georgia, United States of America. Styczynski AR; Department of Infectious Disease, Stanford University, Palo Alto, California, United States of America. Camacho-Ortiz A; Department of Infectious Disease, University Hospital José Eleuterio González, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León, Mexico. Villarino ME; Division of Global Migration and Quarantine, CDC Mexico Country Office, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Belay ED; Division of High-Consequence Pathogens and Pathology-Centers for Disease Control and Prevention, Prion and Public Health Office, Atlanta, Georgia, United States of America. Schonberger LB; Division of High-Consequence Pathogens and Pathology-Centers for Disease Control and Prevention, Prion and Public Health Office, Atlanta, Georgia, United States of America. Sejvar JJ; Division of High-Consequence Pathogens and Pathology-Centers for Disease Control and Prevention, Prion and Public Health Office, Atlanta, Georgia, United States of America.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies